• nirmatrelvir

    Nirmatrelvir/Ritonavir Recommendation 1: In ambulatory patients with mild-to-moderate COVID-19 at high risk for progression to severe disease, the IDSA guideline panel suggests nirmatrelvir/ritonavir initiated within five days of symptom onset rather than no nirmatrelvir/ritonavir. (Conditional recommendation†, Low certainty of evidence) Remarks: • Patients’ medications need to be screened for serious drug interactions • Dosing based […]

  • Norvir

    Ritonavir antiviral ชื่อการค้า : Norvir ขนาดบรรจุ : Applies to the following strength(s): 80 mg/mL ; 100 mg ข้อบ่งใช้ : การติดเชื้อไวรัส HIV , การป้องกันการติดเชื้อ HIV -PEP ขนาด :Oral: as a pharmacokinetic (PK) booster for other protease inhibitors: 100 to 400 mg/day orally in 1 or 2 divided doses Use as an antiretroviral agent (sole protease inhibitor): […]

Related lists

Hospital Lists